216 related articles for article (PubMed ID: 2104180)
21. In vitro production of anti-histone antibodies by spleen cells from young autoantibody negative NZB/NZW mice.
O'Dell JR; Kotzin BL
J Immunol; 1985 Aug; 135(2):1101-7. PubMed ID: 3874228
[TBL] [Abstract][Full Text] [Related]
22. Natural autoantibodies are involved in the haemolytic anaemia of NZB mice.
Hentati B; Payelle-Brogard B; Jouanne C; Avrameas S; Ternynck T
J Autoimmun; 1994 Aug; 7(4):425-39. PubMed ID: 7980846
[TBL] [Abstract][Full Text] [Related]
23. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells.
Murakami M; Yoshioka H; Shirai T; Tsubata T; Honjo T
Int Immunol; 1995 May; 7(5):877-82. PubMed ID: 7547714
[TBL] [Abstract][Full Text] [Related]
24. Effects of transgenic mixed-haplotype MHC class II molecules A alpha d A beta z on autoimmune disease in New Zealand mice.
Nishimura H; Ishikawa S; Nozawa S; Awaji M; Saito J; Abe M; Tokushima M; Kimoto M; Akakura S; Tsurui H; Hirose S; Shirai T
Int Immunol; 1996 Jun; 8(6):967-76. PubMed ID: 8671686
[TBL] [Abstract][Full Text] [Related]
25. Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB x NZW)F1 hybrid.
Alarcón-Riquelme ME; Möller G; Fernández C
Clin Immunol Immunopathol; 1992 Mar; 62(3):264-9. PubMed ID: 1541052
[TBL] [Abstract][Full Text] [Related]
26. Genetic regulation of the class conversion of dsDNA-specific antibodies in (NZB X NZW)F1 hybrid.
Kohno A; Yoshida H; Sekita K; Maruyama N; Ozaki S; Hirose S; Shirai T
Immunogenetics; 1983; 18(5):513-24. PubMed ID: 6642573
[TBL] [Abstract][Full Text] [Related]
27. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
[TBL] [Abstract][Full Text] [Related]
28. Development of autoimmune disease in SCID mice populated with long-term "in vitro" proliferating (NZB x NZW)F1 pre-B cells.
Reininger L; Radaszkiewicz T; Kosco M; Melchers F; Rolink AG
J Exp Med; 1992 Nov; 176(5):1343-53. PubMed ID: 1402680
[TBL] [Abstract][Full Text] [Related]
29. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
Margaritte C; Gilbert D; Brard F; Tron F
J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
[TBL] [Abstract][Full Text] [Related]
30. Macrophage depletion decreases IgG anti-DNA in cultures from (NZB x NZW)F1 spleen cells by eliminating the main source of IL-6.
Alarcón-Riquelme ME; Möller G; Fernández C
Clin Exp Immunol; 1993 Feb; 91(2):220-5. PubMed ID: 8428389
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
Carlsten H; Holmdahl R; Tarkowski A
Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
[TBL] [Abstract][Full Text] [Related]
32. IgG anti-DNA autoantibodies within an individual autoimmune mouse are the products of clonal selection.
Marion TN; Bothwell AL; Briles DE; Janeway CA
J Immunol; 1989 Jun; 142(12):4269-74. PubMed ID: 2786025
[TBL] [Abstract][Full Text] [Related]
33. Effects of prostaglandin E1 on the production of IgM and IgG class anti-dsDNA antibodies in NZB/W F1 mice.
Yoshikawa T; Suzuki H; Sugiyama E; Tunru IS; Ikemoto M; Hori T; Matsui S; Yamashita N; Kobayashi M
J Rheumatol; 1993 Oct; 20(10):1701-6. PubMed ID: 8295181
[TBL] [Abstract][Full Text] [Related]
34. Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia.
Shirai T; Okada T; Hirose S
Ann N Y Acad Sci; 1992 May; 651():509-26. PubMed ID: 1376072
[TBL] [Abstract][Full Text] [Related]
35. Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice.
Cerny A; Starobinski M; Hügin AW; Sutter S; Zinkernagel RM; Izui S
J Immunol; 1987 Jun; 138(12):4222-8. PubMed ID: 3495583
[TBL] [Abstract][Full Text] [Related]
36. Immunologic abnormality in NZB/W F1 mice. Thymus-independent expansion of B cells responding to interleukin-6.
Mihara M; Fukui H; Koishihara Y; Saito M; Ohsugi Y
Clin Exp Immunol; 1990 Dec; 82(3):533-7. PubMed ID: 2265491
[TBL] [Abstract][Full Text] [Related]
37. Enhanced response of autoantibody-secreting B cells from young NZB/NZW mice to T-cell-derived differentiation signals.
Herron LR; Coffman RL; Kotzin BL
Clin Immunol Immunopathol; 1988 Feb; 46(2):314-27. PubMed ID: 3257428
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
39. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells.
Atencio S; Amano H; Izui S; Kotzin BL
J Immunol; 2004 Apr; 172(7):4159-66. PubMed ID: 15034028
[TBL] [Abstract][Full Text] [Related]
40. Contribution of major histocompatibility complex (MHC) to upregulation of anti-DNA antibody in transgenic mice.
Song YW; Tsao BP; Hahn BH
J Autoimmun; 1993 Feb; 6(1):1-9. PubMed ID: 8457281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
